HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Toloxatone

HCID 34521
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
29218-27-7
Standard SMILES
Cc1cccc(N2CC(CO)OC2=O)c1
InChIKey
MXUNKHLAEDCYJL-UHFFFAOYSA-N
Molecular formula
C11H13NO3
Average molar mass
207.23 g/mol
Monoisotopic mass
207.08954328

Overview

5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one is a member of the class of oxazolidinones that is 5-(hydroxymethyl)-1,3-oxazolidin-2-one substituted by a 3-methylphenyl group at position 3. It is a primary alcohol, a member of toluenes and an oxazolidinone.

Names & identifiers

Preferred name
Toloxatone
IUPAC
5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one
English name
Toloxatone
Molecular formula
C11H13NO3
Molecular weight
207.23

Names & synonyms

Toloxatone29218-27-7HumorylPerenumToloxatona5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinoneToloxatonumTaloxotoneDelalande 692765-Hydroxymethyl-3-(m-tolyl)-2-oxazolidinoneDTXSID408654785T206015T5
Show more names
69276MDToloxatone USP/EP/BPToloxatone - MD 69276Toloxatone, 10 mM in DMSO
MD-69276(3-methyl)-3-phenyl-5-hydroxymethyl-2-oxazolidinoneRefChem:898548DTXCID10813880N06AG03CHEBI:134870249-522-25-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one

Database identifiers

CAS
29218-27-7
PubChem CID
34521
DTXSID
DTXSID40865478
ChEMBL
CHEMBL18116
ChEBI
CHEBI:156575
UNII
5T206015T5
EC Number
249-522-2
Nikkaji
J21.701H

Properties

Computed structural properties

XLogP
1.2
Topological polar surface area
49.8 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
2
Heavy atoms
15
Formal charge
0
Complexity
244

Physicochemical properties

Melting point
76 ° · 76°
Boiling point
358.9 · 358.9±21.0 °C(Predicted)
Density
1.245 · 1.245±0.06 g/cm3(Predicted)
storage temp.
2 · Inert atmosphere,2-8°C
solubility
10 mg/mL · DMSO: >10mg/mL
form
solid
pka
14.05 · 14.05±0.10(Predicted)
color
White to off-white
InChI
1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3
InChIKey
MXUNKHLAEDCYJL-UHFFFAOYSA-N
SMILES
Cc1cccc(c1)N2CC(CO)OC2=O
FDA UNII
5 T206015T5 · 5T206015T5
ATC code
6 AG03 · N06AG03
Comptox DTXSID
40865478 · DTXSID40865478
UNSPSC Code
12161501 · 12161501
NACRES
77 · NA.77

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
RQ2867500
ridadr
3249
hs_code
2934999090
Toxicity
LD50 orally in mice (mg/kg): 1850 (Fauran); also reported as 1500 (Raynaud)
risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
hazard_class
6.1(b)
Storage Class
11 - Combustible Solids
packing_group
III
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 2 items

N - Nervous system

QN - Nervous system

PharmacodynamicsThis drug has been shown to help manage the symptoms of depression by maintaining neuro-synaptic levels of serotonin and catecholamines while regulating their metabolism, which leads to relief of depressive symptoms.
Mechanism of Action · 1 item

This medication is a reversible inhibitor of monoamine oxidase type-A (also known as RIMA). MAO-A can be found in norepinephrinergic and serotonergic neurons and regulates the metabolism of serotonin and catecholamines, allowing for increased circulation in the synaptic cleft. Traditional monoamine oxidase inhibitors irreversibly inhibit monoamine oxidase and therefore, side effects, drug interactions, and food interactions persist as long as 2-3 weeks after discontinuing toloxatone. The elevation of serotonin and norepinephrine levels occurs rapidly after medication administration. However, the therapeutic relief of depressive symptoms requires weeks of daily treatment to observe results. Selective and reversible MAO-A inhibitors are more effective in treating major depression without several of the drug and food interactions associated with traditional monoamine oxidase inhibitors.

Biological Half-Life1-3 h
MeSH Pharmacological Classification · 2 items

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
280 · P280-P305+P351+P338
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn
Risk Statements
22 · 22
RIDADR
3249 · 3249
WGK Germany
3 · 3
RTECS
2867500 · RQ2867500
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
2934999090 · 2934999090
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Toxicity
50 orally · LD50 orally in mice (mg/kg): 1850 (Fauran); also reported as 1500 (Raynaud)
Absorption, Distribution and Excretion · 2 items

Mainly hepatic 1% of drug is excreted unchanged in the urine

High hepatic excretion rate

Applications · 2 items

DescriptionToloxatone is a selective, reversible and competitive inhibitor of type A monoamine oxidase (MAO-A) which shows clinical utility as an antidepressant. It is reportedly free of the "cheese effect" in man, possibly due to the reversible nature of its inhibitory effect on intestinal MAO-A in the presence of high concentrations of tyramine.

UsesToloxatone is a monoamine oxidase-A (MAO-A) inhibitor.

Upstream & downstream products

Upstream raw materials

m-ToluidineMethyl chloroformatePropylene glycolPropylene oxide
Additional notes · 1 item

DefinitionChEBI: 5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one is a member of the class of oxazolidinones that is 5-(hydroxymethyl)-1,3-oxazolidin-2-one substituted by a 3-methylphenyl group at position 3. It is a member of toluenes, an oxazolidinone and a primary alcohol.